More Like this

1. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management

   https://doi.org/10.3390/cancers11121836  

   Harris, Jenna C.; Scully, Mackenzie A.; Day, Emily S. (December 2019, Cancers)

   Cancer is a global health problem in need of transformative treatment solutions for improved patient outcomes. Many conventional treatments prove ineffective and produce undesirable side effects because they are incapable of targeting only cancer cells within tumors and metastases post administration. There is a desperate need for targeted therapies that can maximize treatment success and minimize toxicity. Nanoparticles (NPs) with tunable physicochemical properties have potential to meet the need for high precision cancer therapies. At the forefront of nanomedicine is biomimetic nanotechnology, which hides NPs from the immune system and provides superior targeting capabilities by cloaking NPs in cell-derived membranes. Cancer cell membranes expressing “markers of self” and “self-recognition molecules” can be removed from cancer cells and wrapped around a variety of NPs, providing homotypic targeting and circumventing the challenge of synthetically replicating natural cell surfaces. Compared to unwrapped NPs, cancer cell membrane-wrapped NPs (CCNPs) provide reduced accumulation in healthy tissues and higher accumulation in tumors and metastases. The unique biointerfacing capabilities of CCNPs enable their use as targeted nanovehicles for enhanced drug delivery, localized phototherapy, intensified imaging, or more potent immunotherapy. This review summarizes the state-of-the-art in CCNP technology and provides insight to the path forward for clinical implementation. 

   more » « less
2. Nerve-to-cancer transfer of mitochondria during cancer metastasis

   https://doi.org/10.1038/s41586-025-09176-8  

   Hoover, Gregory; Gilbert, Shila; Curley, Olivia; Obellianne, Clémence; Lin, Mike T; Hixson, William; Pierce, Terry W; Andrews, Joel F; Alexeyev, Mikhail F; Ding, Yi; et al (June 2025, Nature)
3. Discovery of primary prostate cancer biomarkers using cross cancer learning

   https://doi.org/https://doi.org/10.1038/s41598-021-89789-x  

   Zhou, K; Arslanturk, S; Craig, D. B; Heath, E; Draghici, S (May 2021, Scientific reports)

   null (Ed.)
4. Predicting time-to-first cancer diagnosis across multiple cancer types

   https://doi.org/10.1038/s41598-025-08790-w  

   Lau, Kien; Hart, Gregory_R; Deng, Jun (July 2025, Scientific Reports)
5. Cancer cell populations

   https://doi.org/10.1016/j.semcancer.2024.12.004  

   Adler, Frederick R; Levine, Herbert; Brock, Amy (February 2025, Seminars in Cancer Biology)